Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG study

Journal of Surgical Oncology

Volumn 81, Issue 3, 2002, Pages 132-137

  Saygili, Ugur ^a   Guclu, Serkan ^a   Uslu, Turhan ^a   Erten, Oktay ^a   Ture, Sevgi ^a   Demir, Namik ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Cytoreduction; Lymphadenectomy; Ovarian carcinoma; Survival

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; PARA-AORTIC BODIES; PELVIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036830609     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10124     Document Type: Article

References (22)

1. Dauplat J, Le Bouedec G, Pomel C, et al.: Cytoreductive surgery for advanced stages of ovarian cancer. Semin Surg Oncol 2000;19:42-48.
2. Staging announcement. FIGO Cancer Committee. Gynecol Oncol 1986;25:383-385.
3. Eisenkop SM, Friedman RL, Wang HJ: Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 1998;69:103-108.
4. Gerhenson DM: Primary cytoreduction for advanced epithelial ovarian cancer. Obstet Gynecol Clin North Am 1994;21:121-140.
5. Hoskins WJ, McGuire WP, Brady MF, et al.: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-980.
6. Vergote I, De Wever I, Tjalma W, et al.: Interval debulking surgery: An alternative for.primary surgical debulking. Semin Surg Oncol 2000;19:49-53.
7. Eisenkop SM, Spirtos NM: What are the current surgical objectives strategies and technical capapabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol 2001;82:489-497.
8. Burghardt E, Peckel H, Lahousen M, et al.: Pelvic RPLND in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986;155:315-319.
9. Di Re F, Fontanelli R, Raspagliesi F, et al.: Pelvic and para-aortic lymphadenectomy in cancer of the ovary. Baillieres Clin Obstet Gynaecol 1989;3:131-142.
10. Burghardt E, Girardi F, Lahousen M, et al.: Patterns of pelvic and para-aortic lymph node involvement in ovarian cancer. Gynecol Oncol 1991;40:103-106.
11. Benedetti-Panici P, Greggi S, Maneschi F, et al.: Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 1993;51:150-154.
12. Wu PC, Lang JH, Huang RL, et al.: Lymph node metastasis and retroperitoneal lymphadenectomy in ovarian cancer. Baillieres Clin Obstet Gynaecol 1989;3:143-155.
13. Onda T, Yoshikawa H, Yokota H: Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. Cancer 1996;78:803-808.
14. Kikkawa F, Ishikawa H, Tamakoshi K, et al.: Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol 1995;60:227-231.
15. Kigawa J, Minagawa Y. Ishihara H, et al.: Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for ovarian cancer. Eur J Surg Oncol 1993;19:273-278.
16. Di Re F, Baiocchi G: Value of lymph node assessment in ovarian cancer: Status of the art at the end of the second millennium. Int J Gynecol Cancer 2000;10:435-442.
17. Yokoyama Y, Sakamoto T, Sato S, et al.: Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer. Eur J Gynaecol Oncol 1999;20:361-366.
18. Di Re F, Baiocchi G, Fontanelli R, et al.: Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: Prognostic significance of node metastases. Gynecol Oncol 1996;62:360-365.
19. Parazzini F, Valsecchi G, Bolis G, et al.: Pelvic and paraaortic lymph nodal status in advanced ovarian cancer and survival. Gynecol Oncol 1999;74:7-11.
20. Petru E, Lahousen M, Tamussino K, et al.: Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-662.
21. Arango HA, Hoffman MS, Roberts WS, et al.: Accuracy of lymph node palpation to determine need for lymphadenectomy in gynecologic malignancies. Obstet Gynecol 2000;95:553-556.
22. Franchi M, Ghezzi F, Riva C, et al.: Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol 2001;78:232-240.